In the present study, we demonstrated that Celastrol could greatly inhibit atopic dermatitis-related tissue injury, mast cell production, histamine release, scratching level, inflammatory factor expression, and activation of the MRGPRX2/ORAI axis in the DNFB-induced atopic dermatitis model. The gene discussed is MRGPRX2; the disease is atopic eczema.